|
DCL: BoD approves to seek shareholders’ written approval On May 11, 2016, the Board of Directors of Cuu Long Pharmaceutical Joint Stock Corporation approved to seek shareholders’ written approval:
1) Approving the content of seeking shareholders’ written approval: the adjustment to the transfer restriction period for ESOP-2015 shares:
- Total number of issue shares: 145,788 shares
- Transfer restriction period: 03 years from May 19, 2015 to May 18, 2018
2) Approving a record date for seeking shareholders’ written approval:
- Record date: May 27, 2016
- Exercise ratio: 01 share – 01 voting right
- Time of implementation: in June 2016 HOSE
|
